China+1 Boosts India’s Share In Pharma Beyond Generics
27 Jan 2025 //
ECONOMICTIMES
Lupin gets USFDA nod for generic HIV drug
24 Jan 2025 //
ECONOMICTIMES
Piramal Pharma launches Chlorpromazine Hydrochloride in US
23 Jan 2025 //
BUSINESS STD
Piramal Launches Chlorpromazine Hydrochloride Injection In US
23 Jan 2025 //
EXPRESSPHARMA
Sarclisa Approved In EU As 1st Anti-CD38 For Multiple Myeloma
22 Jan 2025 //
PRESS RELEASE
Sunshine Biopharma launches Olanzapine and Olanzapine ODT
22 Jan 2025 //
INDPHARMAPOST
Strides gains FDA approval for Acetaminophen and Ibuprofen
20 Jan 2025 //
EXPRESSPHARMA
China Looks Into Generic Drug Quality After Doctors Speak Up
20 Jan 2025 //
ECONOMICTIMES
Novartis wins 11th-hour bid to block Entresto generic from MSN
17 Jan 2025 //
FIERCE PHARMA
Novartis wins temporary pause to Entresto generic launch in US
16 Jan 2025 //
REUTERS
Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets
15 Jan 2025 //
EXPRESSPHARMA
Lupin launches Minzoya in the US
14 Jan 2025 //
PRESS RELEASE
Court Approves First Settlements In Generic Drug Price-Fixing Case
14 Jan 2025 //
PR NEWSWIRE
Court Approves Settlements In Generic Price Conspiracy
13 Jan 2025 //
PR NEWSWIRE
Lupin Gets Tentative U.S. FDA Approval For Ivacaftor Oral Granules
10 Jan 2025 //
EXPRESSPHARMA
Catalyst`s Teva settlement postpones arrival of Firdapse generic
09 Jan 2025 //
FIERCE PHARMA
Novo petitions FDA over Victoza compounding as generic win approval
06 Jan 2025 //
FIERCE PHARMA
Kwality Pharma gains on securing SAHPRA approval for Tamoxifen
24 Dec 2024 //
BUSINESS STD
Alembic Pharma gets USFDA nod for seizure treatment drug
20 Dec 2024 //
BUSINESS STD
Zydus gets USFDA nod for generic topical anaesthetic cream
19 Dec 2024 //
ECONOMICTIMES
Breckenridge Receives FDA Approval for Methadone HCl Injection
18 Dec 2024 //
PR NEWSWIRE
Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL
18 Dec 2024 //
INDPHARMAPOST
Pharma lobby, govt meet to discuss OTC drug regulation
17 Dec 2024 //
ECONOMICTIMES
bioAffinity Technologies Hosts Live Investor Webinar on December 19
17 Dec 2024 //
BUSINESSWIRE
Granules India gets USFDA nod for ADHD Treatment
17 Dec 2024 //
PRESS RELEASE
Sandoz Resolves US Generic Drug Antitrust Litigation
17 Dec 2024 //
GLOBENEWSWIRE
Glenmark Pharma arm launches seizure drug in US
16 Dec 2024 //
BUSSINESS STD
Gland Pharma Gets FDA Approval For Phytonadione Injectable
11 Dec 2024 //
BUSINESS STD
Eugia Pharma receives FDA approval for Pazopanib Tablets, 200 mg
09 Dec 2024 //
INDPHARMAPOST
Pharma firm Teva to divest its business venture in Japan
07 Dec 2024 //
REUTERS
Lupin receives FDA tentative approval for HIV treatment generic
07 Dec 2024 //
EXPRESSPHARMA
Novartis` latest bid to block MSN`s generic comes up short
06 Dec 2024 //
FIERCE PHARMA
Auro Pharma arm gets USFDA nod for Pazopanib tabs
05 Dec 2024 //
BUSINESS STD
Alembic Pharma gets tentative USFDA nod for Olopatadine drug
04 Dec 2024 //
BUSINESS STD
Sunshine Biopharma Launches a New Generic Prescription Drug
04 Dec 2024 //
ACCESSWIRE
Gland Pharma secures FDA approval for Latanoprost Solution
03 Dec 2024 //
EXPRESSPHARMA
FDA Confirms Para IV Patent Litigation for Crextont Capsules
03 Dec 2024 //
FDA
FDA Confirms Para IV Patent Litigation for Qdolo Oral Solution
03 Dec 2024 //
FDA
Strengthening Drug Security Through Resilient, Supply Chain
30 Nov 2024 //
EXPRESSPHARMA
FDA gives tentative approval to Lupin’s for treat type 2 diabetes
30 Nov 2024 //
FINANCIALXPRESS
Glenmark Pharma arm launches Travoprost Ophthalmic Solution in US
27 Nov 2024 //
BUSINESS STD
Senores Pharma Launches Ivermectin Tablets In US With Dr. Reddy’s
26 Nov 2024 //
PRESS RELEASE
Amneal Wins FDA Nod for GLP-1 Generic
22 Nov 2024 //
BIOSPACE
Sunshine Biopharma Launches a New Generic Prescription Drug
22 Nov 2024 //
ACCESSWIRE
Marksans gets USFDA nod for allergic rhinitis treatment tablets
22 Nov 2024 //
BUSINESS STD
Amneal Resubmits DHE Autoinjector NDA; FDA Approves Exenatide
22 Nov 2024 //
BUSINESSWIRE
Natco submits ANDA with USFDA for Risdiplam for Oral solution
21 Nov 2024 //
BUSINESS STD
Lupin receives FDA approval for generic version of Adderall XR
21 Nov 2024 //
EXPRESSPHARMA
Lupin launches Bumetanide Injection USP in US
20 Nov 2024 //
PRESS RELEASE
Roche files patent suit to fend off potential Evrysdi generics
20 Nov 2024 //
FIERCE PHARMA
BeiGene defends Brukinsa from MSN`s generic threat until 2037
19 Nov 2024 //
FIERCE PHARMA
Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug
18 Nov 2024 //
REUTERS
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Alembic Pharma Gains USFDA Approval for Ivabradine Tablets
12 Nov 2024 //
EXPRESSPHARMA
Alembic Pharma gets FDA nod for Diltiazem HCl ER capsules
11 Nov 2024 //
BUSINESS STD
Lupin receives tentative FDA approval for Raltegravir tablets
11 Nov 2024 //
EXPRESSPHARMA
Hefty sales of generics boost Teva to another big quarter
07 Nov 2024 //
FIERCE PHARMA
Teva Reports Strong Q3 2024 Results, Raises Financial Outlook
06 Nov 2024 //
GLOBENEWSWIRE
Walgreens agrees to pay $100 mlnt over generic drug pricing
04 Nov 2024 //
REUTERS
AVET Pharma Settles Antitrust Case in Generic Pharma Pricing
04 Nov 2024 //
PR NEWSWIRE